The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.
The DCP Cancer Biomarkers Research Group administers this program.
Visit the EDRN website
The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.
In the News: 34th Steering Committee Meeting of the EDRN
The 34th Steering Committee Meeting of the NCI Early Detection Research Network (EDRN) is joined by the investigators engaged in biomarker research and supported by Japan Agency for Medical Research and Development (AMED). This meeting takes place March 18-20, 2019.